lobbying_activities: 1872885

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1872885	5a3626de-d4c4-4718-b320-caad1eda0a4a	Q3	DRUG POLICY ALLIANCE	68651	DRUG POLICY ALLIANCE	2016	third_quarter	HCR	Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.	HOUSE OF REPRESENTATIVES,SENATE		80000	0	0	2016-10-03T16:38:42.297000-04:00